Pacer Advisors
ALT icon

Pacer Advisors’s Altimmune ALT Stock Holding History

Pacer Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,260
Closed -$8.38K – 2562
2024
Q2 		$8.38K Sell
1,260
-2,899
-70% -$21.4K ﹤0.01% 3580
2024
Q1 		$42.3K Buy
+4,159
New +$42.3K ﹤0.01% 3234
2021
Q2 		– Sell
-4,650
Closed -$66K – 1411
2021
Q1 		$66K Buy
+4,650
New +$75.2K ﹤0.01% 1394

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pacer Advisors's ALT Position: Q3 2024 in Review

Pacer Advisors sold out of Altimmune (ALT) in Q3 2024, closing a stake of 1,260 shares — an estimated $8.38K sold.

Pacer Advisors first reported a position in ALT in Q1 2021 and held it in 3 quarters. The position peaked at $66K in Q1 2021. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • Pacer Advisors reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 1,260 Altimmune shares in Q3 2024, an estimated $8.38K.
  • Pacer Advisors first reported a position in Altimmune in Q1 2021 and held it in 3 quarters.
  • Pacer Advisors's Altimmune position peaked at $66K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.